{"name":"MEDICAL ENGINEERING TECHNOLOGIES LTD.","company_number":"03295099","status":"Active","type":"Private Limited Company","incorporated":"1996-12-20","dissolved":null,"registered_office":"Unit 16 Holmestone Road, Dover, Kent, CT17 0UF","postcode":"CT17 0UF","sic_codes":[{"code":72190,"description":"Other research and experimental development on natural sciences and engineering"}],"principal_activity":"The principal activity of the company is that of laboratory testing services.","previous_names":[{"name":"CAMPUS MEDICAL LIMITED","changed_on":"1997-08-13"}],"warnings":[],"accounts":{"category":"Audit Exemption Subsidiary","year_end":"29 September","last_made_up_to":"2025-09-30","next_due":"2027-06-29"},"employees":{"count":27,"accounts_date":"2022-09-30"},"financials":[{"financial_date":"2022-09-30","net_assets":2254821,"cash":711066,"average_employees":27},{"financial_date":"2021-12-31","net_assets":1628165,"cash":1120791,"average_employees":25},{"financial_date":"2020-12-31","net_assets":1385711,"cash":841794},{"financial_date":"2019-12-31","net_assets":995249,"cash":392801},{"financial_date":"2018-12-31","net_assets":918716,"cash":433075}],"officers":{"current":3,"resigned":8,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":0,"outstanding":0},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Medical Engineering Technologies presents a fundamentally strong standalone profile — 29 years of continuous trading, net assets grown tenfold since 2013 to £2.25m funded entirely from retained profits, minimal leverage and current filings — but the 2022 acquisition by the WMP Bidco group materially changes the risk picture. The most recent accounts appear to be filed under the subsidiary audit exemption, a £1.6m debtor balance of apparently non-trade character now dominates the balance sheet, and no financial data is available for the three years to September 2025. On the available evidence the company is not a solvency concern, but counterparty exposure should be treated as MEDIUM until the current accounts and the wider group's leverage position are reviewed.","website":null,"links":{"page":"https://www.companiesintheuk.co.uk/ltd/medical-engineering-technologies","people":"https://www.companiesintheuk.co.uk/company/medical-engineering-technologies/people","filing_history":"https://www.companiesintheuk.co.uk/company/medical-engineering-technologies/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/03295099","financials":"https://www.companiesintheuk.co.uk/company/medical-engineering-technologies/financial","control":"https://www.companiesintheuk.co.uk/company/medical-engineering-technologies/control","charges":"https://www.companiesintheuk.co.uk/company/medical-engineering-technologies/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/medical-engineering-technologies/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/medical-engineering-technologies"}